The agreement is between Chinese firm Jiangsu Acebright and Cipla's European arm, Cipla EU for a combined investment of USD 30 million, as per a company statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ll5OUQ
via IFTTT
Cipla forms JV with Jiangsu Acebright for respiratory medicines in China
The agreement is between Chinese firm Jiangsu Acebright and Cipla's European arm, Cipla EU for a combined investment of USD 30 million, as per a company statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ll5OUQ
via IFTTT
0 comments:
Post a Comment